Paxlovid speeds COVID-19 recovery but does not reduce hospital admissions

Across two trials, more than 4,000 patients were randomised to receive usual care or Paxlovid (nirmatrelvir and ritonavir; Pfizer) within three or four days of symptom onset.…
Published: 24 April 2026